Konakion

Phytomenadione, the active ingredient in Konakion, is a Vitamin K presented as a sterile solution for intramuscular, intravenous, and oral use. It is employed to treat vitamin K deficiency, prevent and treat hemorrhage in newborns, and reverse the effects of anticoagulant therapy.

GNH USA supplies Konakion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Konakion, a vitamin K analogue, acts on the coagulation cascade to restore clotting factor activity. - Vitamin K deficiency: restores functional clotting factors in patients with deficient vitamin K levels. - Newborn hemorrhage: prevents and treats bleeding in neonates by providing essential vitamin K. - Anticoagulant reversal: counteracts the effects of vitamin K antagonist anticoagulants during emergency situations.

Adverse reactions may occur with the use of Konakion and should be monitored.

Common Side Effects: - Injection site pain: mild discomfort at the site of administration. - Erythema: localized redness around the injection area. - Nausea: occasional feeling of queasiness after dosing. - Headache: mild to moderate headache reported by some patients. - Dizziness: transient light‑headedness post‑administration. - Fever: low‑grade temperature elevation in rare cases.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe bleeding: paradoxical worsening of hemorrhage. - Thrombosis: formation of abnormal clots in vessels. - Hemolysis: destruction of red blood cells. - Serum sickness: immune complex mediated reaction. - Hypersensitivity reactions: including rash, swelling, and respiratory distress.

Prior to initiating therapy with Konakion, several safety considerations are recommended. - Assess vitamin K status: verify deficiency before administration. - Monitor coagulation parameters: check PT/INR regularly to gauge effectiveness. - Use with caution in newborns: dose according to weight and clinical guidelines. - Avoid in patients with known hypersensitivity to phytomenadione or its excipients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Konakion may interact with other medications affecting coagulation or vitamin K metabolism.

Major Interactions (Avoid): - Warfarin: antagonistic effect may reduce anticoagulant efficacy. - Direct oral anticoagulants (e.g., dabigatran, rivaroxaban): may diminish therapeutic anticoagulation. - Vitamin K antagonist rodenticides: concurrent exposure can lead to unpredictable clotting.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics (e.g., cephalosporins): may alter gut flora and affect vitamin K levels. - Barbiturates and phenobarbital: can increase vitamin K metabolism, reducing effectiveness.